National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

Federal Register, Volume 80 Issue 173 (Tuesday, September 8, 2015)

Federal Register Volume 80, Number 173 (Tuesday, September 8, 2015)

Notices

Page 53817

From the Federal Register Online via the Government Publishing Office www.gpo.gov

FR Doc No: 2015-22497

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Health Disparity SBIR Review (2016/01).

Date: October 23, 2015.

Time: 10 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).

Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Suite 952, Bethesda, MD 20892, 301-451-

4794, hlastadj@mail.nih.gov.

Dated: September 1, 2015.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

FR Doc. 2015-22497 Filed 9-4-15; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT